antipyrine has been researched along with 1-aminobenzotriazole in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Federowicz, DA; Kerns, W; Mico, BA; Ripple, MG | 1 |
| Balani, SK; He, B; Lee, FW; Liu, Z; Yang, TJ; Zhu, T | 1 |
| Balani, SK; Cardoza, K; Gan, LS; Lee, FW; Li, P; Mu, DX; Nguyen, J; Wu, JT; Zeng, H | 1 |
| Deshmukh, SV; Durston, J; Shomer, NH | 1 |
| Igeta, K; Suzuki, N; Takahashi, M; Washio, T; Yamashita, S | 1 |
| Nezasa, K; Ogawa, K; Shimizu, R; Takai, N; Tanaka, Y; Watanabe, A; Watari, R; Yamaguchi, Y | 1 |
| Ferreira, S; Ronseaux, S; Rose, J; Stringer, RA | 1 |
| Mayumi, K; Nishimura, K; Osaki, H; Watanabe, A | 1 |
8 other study(ies) available for antipyrine and 1-aminobenzotriazole
| Article | Year |
|---|---|
In vivo inhibition of oxidative drug metabolism by, and acute toxicity of, 1-aminobenzotriazole (ABT). A tool for biochemical toxicology.
Topics: Acetaminophen; Animals; Antipyrine; Biotransformation; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Oxidation-Reduction; Phenacetin; Rats; Triazoles | 1988 |
Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Dogs; Humans; Macaca fascicularis; Male; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley; Triazoles | 2002 |
Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in guinea pigs and mice using serial sampling.
Topics: Animals; Antipyrine; Dose-Response Relationship, Drug; Gas Chromatography-Mass Spectrometry; Guinea Pigs; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Triazoles | 2004 |
Validation of the use of nonnaive surgically catheterized rats for pharmacokinetics studies.
Topics: Animals; Antipyrine; Catheterization; Cost-Benefit Analysis; Femoral Artery; Hematocrit; Jugular Veins; Male; Pharmacokinetics; Quinidine; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Surgical Procedures, Operative; Terfenadine; Time Factors; Triazoles | 2008 |
Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.
Topics: Administration, Oral; Animals; Antipyrine; Biological Availability; Cytochrome P-450 Enzyme Inhibitors; Inactivation, Metabolic; Intestinal Absorption; Intestinal Mucosa; Macaca fascicularis; Perfusion; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Reference Values; Triazoles | 2010 |
Using improved serial blood sampling method of mice to study pharmacokinetics and drug-drug interaction.
Topics: Administration, Intravenous; Administration, Oral; Animals; Antipyrine; Biological Availability; Blood Specimen Collection; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Monitoring; Ibuprofen; Male; Mice, Inbred C57BL; Models, Animal; Organic Anion Transporters; Pravastatin; Reproducibility of Results; Rifampin; Tail; Terfenadine; Triazoles; Veins | 2015 |
Application of Osmotic Pumps for Sustained Release of 1-Aminobenzotriazole and Inhibition of Cytochrome P450 Enzymes in Mice: Model Comparison with the Hepatic P450 Reductase Null Mouse.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Genotype; Infusion Pumps, Implantable; Infusions, Subcutaneous; Injections, Subcutaneous; Liver; Male; Mice, Knockout; Osmotic Pressure; Phenotype; Triazoles | 2016 |
In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice.
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme Inhibitors; Male; Mice, Inbred C57BL; Osmosis; Triazoles | 2016 |